Checkpoint Responses in Cancer Therapy (Cancer Drug Discovery and Development) - Image 1

£144.18

Humana Checkpoint Responses in Cancer Therapy (Cancer Drug Discovery and Development)

Name: Checkpoint Responses in Cancer Therapy (Cancer Drug Discovery and Development)
Brand: Humana
Price: 144.18 GBP
Availability: InStock

Oncology

About as cheap as it gets. The only time it was cheaper was 1 year ago.

£144 today · all-time low £139 (Mar 2025) · usually the usual

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 638 days • 638 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 638 days • 6 price levels

Days at Price

Current Price

Price Analysis

Most common price: £143 (208 days, 32.6%)

Price range: £139 - £180

Price levels: 6 different prices over 638 days

Description

Extensive research has uncovered a set of molecular surveillance mechanisms – commonly called “checkpoints” – which tightly monitor cell-cycle processes. Today’s anticancer drug development has identified many of these cell-cycle checkpoint molecules as effective targets. Research now promises to uncover a new generation of anticancer drugs with improved therapeutic indices based on their ability to target emerging checkpoint components. Checkpoint Responses in Cancer Therapy summarizes the advances made over the past 20 years, identifying components of cell-cycle checkpoints and their molecular regulation during checkpoint activation and validating the use of checkpoint proteins as targets for the development of anticancer drugs. This book’s distinguished panel of authors takes a close look at topics ranging from the major molecular players affecting DNA synthesis and the response to DNA damage to advances made in the identification of chemical compounds capable of inhibiting individual mitotic kinases. Illuminating and authoritative, Checkpoint Responses in Cancer Therapy offers a critical summary of findings for researchers in the pharmaceutical and biotechnology industries and a valuable resource for academic scientists in cancer research and the study of cell-cycle regulation, signal transduction and apoptosis. From the Back Cover Extensive research has uncovered a set of molecular surveillance mechanisms – commonly called "checkpoints" – which tightly monitor cell-cycle processes. Today’s anticancer drug development has identified many of these cell-cycle checkpoint molecules as effective targets. Research now promises to uncover a new generation of anticancer drugs with improved therapeutic indices based on their ability to target emerging checkpoint components. Checkpoint Responses in Cancer Therapy summarizes the advances made over the past 20 years, identifying components of cell-cycle checkpoints and their molecular regulation during checkpoint activation and validating the use of checkpoint proteins as targets for the development of anticancer drugs. This book’s distinguished panel of authors takes a close look at topics ranging from the major molecular players affecting DNA synthesis and the response to DNA damage to advances made in the identification of chemical compounds capable of inhibiting individual mitotic kinases. Illuminating and authoritative, Checkpoint Responses in Cancer Therapy offers a critical summary of findings for researchers in the pharmaceutical and biotechnology industries and a valuable resource for academic scientists in cancer research and the study of cell-cycle regulation, signal transduction and apoptosis.

Product Specifications

Brand: Humana
Format: Paperback
ASIN: 161737847X
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Diseases & Disorders > Oncology
Domain: Amazon UK
Release Date: 19 November 2010
Listed Since: 11 July 2010

Barcode

No barcode data available

Humana Checkpoint Responses in Cancer Therapy (Cancer Drug Discovery and Development)

About as cheap as it gets. The only time it was cheaper was 1 year ago.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Humana Cell Cycle Checkpoints: Methods and Protocols 782

Humana Cancer Cell Signaling: Methods and Protocols 218

Stress Response Pathways in Cancer: From Molecular Targets to Novel Therapeutics

TCTP/tpt1 - Remodeling Signaling from Stem Cell to Disease: 64 (Results and Problems in Cell Differentiation, 64)

Intercellular Communication in Cancer

Cancer Cell Culture: Methods and Protocols: 731 (Methods in Molecular Biology, 731)

Cancer Biology

Circulating Tumor Cells in Breast Cancer Metastatic Disease: 1220 (Advances in Experimental Medicine and Biology, 1220)

Cancer Epigenetics for Precision Medicine: Methods and Protocols: 1856 (Methods in Molecular Biology, 1856)

Metastasis Research Protocols: 1070 (Methods in Molecular Biology, 1070)

Isolation and Molecular Characterization of Circulating Tumor Cells: 994 (Advances in Experimental Medicine and Biology, 994)

Cancer Stem Cell Resistance to Targeted Therapy: 19 (Resistance to Targeted Anti-Cancer Therapeutics, 19)

Immune Mediators in Cancer: Methods and Protocols: 2108 (Methods in Molecular Biology, 2108)

Humana Circulating Tumor Cells: Methods and Protocols 1634

Cancer Drug Resistance: Overviews and Methods: 1395 (Methods in Molecular Biology, 1395)

The Cell Cycle and Development: 237 (Novartis Foundation Symposia)

Circulating Tumor Cells: Methods and Protocols: 1634 (Methods in Molecular Biology, 1634)

Cancer Management in Man: Chemotherapy, Biological Therapy, Hyperthermia and Supporting Measures: 13 (Cancer Growth and Progression, 13)

Cell Cycle Deregulation in Cancer (Current Cancer Research)

Mathematical Modelling of the Cell Cycle Stress Response (Springer Theses)

Molecular Biology of Cancer: Mechanisms, Targets, and Therapeutics

Tumor Suppressor Genes in Human Cancer (Cancer Drug Discovery and Development)

Academic Press Monitoring Vesicular Trafficking Volume 165

Tumor Dormancy, Quiescence, and Senescence, Volume 1: Aging, Cancer, and Noncancer Pathologies (Tumor Dormancy and Cellular Quiescence and Senescence, 1)